Chester County News and Community Website
WILMINGTON, DE — Incyte (Nasdaq: INCY) has entered a strategic collaboration with Edison Scientific to integrate an artificial intelligence platform across portions of its drug discovery and development operations, reflecting …
Incyte Expands AI Role in Drug Discovery Read More
PHILADELPHIA, PA — Society for Industrial and Applied Mathematics selected mathematician and biomedical researcher Magnus Fontes to deliver its 2026 I. E. Block Community Lecture, spotlighting the growing role of …
SIAM Taps Roche Researcher for 2026 Block Lecture Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration is seeking public input on expanding the use of existing approved medicines for new diseases and patient populations, part of a …
FDA Explores Wider Use of Existing Drugs for Chronic Disease Read More
WASHINGTON, D.C. — Federal regulators have cleared the way for certain pancreatic cancer patients to access an experimental drug earlier than usual, approving a rapid pathway that allows treatment outside …
FDA Fast-Tracks Access to Experimental Pancreatic Drug Read More
WASHINGTON, D.C. — Federal regulators are moving to speed up drug development by launching real-time clinical trials that allow safety data and results to be reviewed as studies are underway …
FDA Pushes Faster Drug Approvals With Real-Time Trials Read More
WASHINGTON, D.C. — Federal regulators say efforts to reduce animal testing in drug development are advancing, with the Food and Drug Administration reporting early progress on a plan aimed at …
FDA Push to Cut Animal Testing Shows Early Progress Read More
WASHINGTON, D.C. — President Donald J. Trump has signed an executive order directing federal agencies to accelerate research, regulatory review, and potential patient access for experimental psychedelic drugs aimed at …
Trump Order Expands Federal Push on Psychedelic Therapies Read More
WASHINGTON, D.C. — Federal regulators are moving to reduce the use of animal testing in drug development, issuing new guidance to help drugmakers adopt alternative methods that rely on human-based …
FDA Push to Replace Animal Testing Signals Major Shift Read More
WILMINGTON, DE — A $30 million federal research initiative is taking aim at one of drug development’s most stubborn and costly blind spots: predicting how the human heart will respond …
Virtual Hearts, Real Stakes: $30M ARPA-H Bet Targets Drug Cardiac Risk Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced an ambitious effort to modernize drug testing by reducing reliance on animal models in favor of advanced, human-relevant …
FDA to Replace Animal Testing with Human-Relevant Methods for Drug Development Read More